Clinical Evidence-Led Oncology
The Limits of Precision—and the Problem of Resistance: Why Enhancing Treatment, Not Replacing It, May Be Oncology’s Next Frontier
2026-05-06
[Illustrations] 2026 AACR Spotlights Three Key Frameworks: Precision Oncology Shifts from Reactive Treatment to Early Interception and Data-Driven Targeting
2026-05-05





